Peloton Therapeutics
develops novel small molecule therapies for the treatment of cancer... Read morePeloton Therapeutics
develops novel small molecule therapies for the treatment of cancer... Read more
News
May 22, 2019
BioPortfolio
Peloton Therapeutics: MSD buys Peloton Therapeutics in deal worth $2.1 billion httpbit.ly2HzD8oh pharmapic.twitter.comx617QWBFjx
May 22, 2019
The Pharma Letter
Peloton Therapeutics: Merck bolstering oncology pipeline via $2.2 billion acquisition
May 21, 2019
BioCentury
Peloton Therapeutics: Merck bets on HIF2As with Peloton takeout ahead of planned listing
May 21, 2019
Reuters
Peloton Therapeutics: REFILE-UPDATE 2-Merck buys Peloton to expand its kidney cancer treatment portfolio
May 17, 2019
MarketWatch
Peloton Therapeutics: IPO Report: Three biotechs are going public next week. Here's what you should know about them
May 13, 2019
4-traders
Peloton Therapeutics: Cboe Global Markets : Peloton Therapeutics Sees Up to 9.4M Share IPO Priced $15-$17/Share
Apr 29, 2019
BioPortfolio
Peloton Therapeutics: Peloton Therapeutics Plans IPO for Kidney Cancer Drug Clinical Trials
Apr 29, 2019
Xconomy
Peloton Therapeutics: Peloton Therapeutics Plans IPO for Kidney Cancer Drug Clinical Trials
Apr 01, 2019
BioPortfolio
Peloton Therapeutics: Peloton Therapeutics Announces Clinical Data Update for PT2977 at European International Kidney Cancer Symposium
Feb 20, 2019
Xconomy
Peloton Therapeutics: Peloton Therapeutics Raises $150M to Advance Kidney Cancer Therapy
Peloton Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10